Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

被引:7
|
作者
Kikut, Justyna [1 ]
Jasinska, Anna [1 ]
Poblocki, Jakub [2 ]
Brodowski, Jacek [3 ]
Malgorzata, Szczuko [1 ]
机构
[1] Pomeranian Med Univ, Dept Human Nutr & Metabol, Broniewskiego 24, PL-71460 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Endocrinol Metab Dis & Internal Dis, Unii Lubelskiej 1, PL-70252 Szczecin, Poland
[3] Pomeranian Med Univ, Primary Care Dept, Zolnierska 48, PL-71210 Szczecin, Poland
关键词
neuroendocrine neoplasms; gastroenteropancreatic neuroendocrine neoplasms; nutrition; methods of nutrition; nutritional status; RISK-FACTORS; VITAMIN-D; TUMORS; IMPACT; HEALTH; CANCER; DEFICIENCIES; MORTALITY; THERAPY; DISEASE;
D O I
10.3390/nu12071961
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: In recent decades, the number of gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) cases, associated with coexisting metabolic disorders, has been continuously increasing. Patients with progressing neoplastic disease are at a risk of malnutrition. To improve the quality of life of neuroendocrine neoplasms (NEN) patients, the therapeutic approach should be supported by a well-balanced diet. The aim of the study was to analyze the nutritional errors and deficits in a group of GEP-NET patients. Materials and methods: The study group included 26 GEP-NET patients; 13 men and 13 women. The mean age of women was 68.77 +/- 8.0, and the mean age of men was 64.69 +/- 8.1. Three interviews on consumption in the last 24 h were performed, in order to evaluate the quality and quantity of nutrition. The data was incorporated into a dietetics software, which allows one to calculate the number of over 58 micronutrients and macronutrients with the participation of 52 menus. Subsequently, the mean values were compared with the current nutritional standards. Results: An energy deficit was observed in the group of women-76.9%, and men-100%, as well as high fat consumption in 23.1% in both groups. The proportions of SFA/MUFA/PUFA were very negative, whereas the consumption of saccharose was too high. Vitamin D deficiency was observed in 100% of men and women. Moreover, both men and women experienced the deficiency of vitamin E, folates and niacin. The consumption of sodium and phosphorus was twice as high as recommended, and an insufficient supply of calcium was observed in 80% of women and 90% of men. The insufficient consumption of magnesium, iodine and potassium in a significant part of the studied group was observed. All participants consumed too much cholesterol and insufficient amounts of fiber. The healthy diet indicator (HDI) and diet quality index (DQI) scores were 3.1 +/- 1.8 (HDI) and 3.7 +/- 1.6 (DQI) for women, and 7.2 +/- 2.6 (HDI) and 8.5 +/- 2.4 (DQI) for men. Conclusions: When analyzing the nutrition of GEP-NET patients, we highlight that they do not have a proper diet, despite the fact that they changed the way they eat. Dietetics support and the development of official nutritional standards seem to be a necessary element in the therapy of GEP-NET patients.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [41] Retrospective Analysis of Gastroenteropancreatic Neuroendocrine Neoplasms and the Role of GSK-3β Expression in Neuroendocrine Neoplasms
    Hu, Y.
    Fan, Y.
    Niu, W.
    Jing, J.
    Shi, Y.
    Li, E.
    Wu, Y.
    [J]. NEUROENDOCRINOLOGY, 2018, 106 : 30 - 30
  • [42] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Venizelos, Andreas
    Sorbye, Halfdan
    Elvebakken, Hege
    Perren, Aurel
    Lothe, Inger Marie B.
    Couvelard, Anne
    Hjortland, Geir Olav
    Sundlov, Anna
    Svensson, Johanna
    Garresori, Harrish
    Kersten, Christian
    Hofsli, Eva
    Detlefsen, Soenke
    Vestermark, Lene W.
    Ladekarl, Morten
    Tabaksblat, Elizaveta Mitkina
    Knappskog, Stian
    [J]. ENDOCRINE-RELATED CANCER, 2023, 30 (10)
  • [43] Bone loss and whole-body composition in patients with gastroenteropancreatic neuroendocrine neoplasms
    Aktypis, C.
    Tsoli, M.
    Yavropoulou, M.
    Efstathopoulos, E.
    Kassi, E.
    Papatheodoridis, G.
    Kaltsas, G.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 59 - 59
  • [44] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Venizelos, A.
    Perren, A.
    Couvelard, A.
    Hjortland, G. O.
    Sundlov, A.
    Svensson, J.
    Garresori, H.
    Vestermark, L. W.
    Tabaksblat, E.
    Elvebakken, H.
    Knappskog, S.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 35 - 35
  • [45] Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms
    Xie, Si
    Li, Lei
    Wang, Xiaotong
    Li, Lequn
    [J]. MEDICINE, 2021, 100 (02) : E24223
  • [46] Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms
    Kloeppel, Guenter
    La Rosa, Stefano
    [J]. VIRCHOWS ARCHIV, 2018, 472 (03) : 341 - 349
  • [47] Primary Neuroendocrine Neoplasms of the Kidney, a Distinct Entity but Classifiable-Like the Gastroenteropancreatic Neuroendocrine Neoplasms
    Amin, Manik
    Chatterjee, Deyali
    [J]. PANCREAS, 2020, 49 (03) : 462 - 462
  • [48] Can PET/CT Guide the Personalized Treatment of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms?
    Schillaci, Orazio
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) : 1757 - 1758
  • [49] Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms
    Günter Klöppel
    Stefano La Rosa
    [J]. Virchows Archiv, 2018, 472 : 341 - 349
  • [50] Advances in the treatment of gastroenteropancreatic neuroendocrine neoplasms with somatostatin analogs
    Lu, Ming
    Zhang, Panpan
    Zhang, Jianwei
    Li, Jie
    [J]. JOURNAL OF PANCREATOLOGY, 2023, 6 (01) : 23 - 27